Collagen-Based Osteogenic Nanocoating of Microrough Titanium Surfaces

• Published in: International journal of molecular sciences Vol. 23; no. 14; p. 7803
• Main Authors: Behrens, Christina, Kauffmann, Philipp, von Hahn, Nikolaus, Schirmer, Uwe, Liefeith, Klaus, Schliephake, Henning
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 15.07.2022; MDPI
• Subjects: Adsorption; Alkaline phosphatase; Anticoagulants; Binding sites; Biomedical materials; Bone implants; bone morphogenic proteins; Cell proliferation; Coatings; Collagen; controlled release; Crosslinking; Experiments; Growth factors; Heparin; Mesenchyme; Morphology; Multilayers; Peptides; polyelectrolyte multilayer; Polyelectrolytes; recombinant proteins; Stem cells; Titanium alloys; Transplants & implants; Germany
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23147803

The aim of the present study was to develop a collagen/heparin-based multilayer coating on titanium surfaces for retarded release of recombinant human bone morphogenic protein 2 (rhBMP2) to enhance the osteogenic activity of implant surfaces. Polyelectrolyte multilayer (PEM) coatings were constructed on sandblasted/acid-etched surfaces of titanium discs using heparin and collagen. PEM films of ten double layers were produced and overlayed with 200 µL of a rhBMP2 solution containing 15 µg rhBMP2. Subsequently, cross-linking of heparin molecules was performed using EDC/NHS chemistry to immobilize the incorporated rhBMP2. Release characteristics for 3 weeks, induction of Alkaline Phosphatase (ALP) in C2C12 cells and proliferation of human mesenchymal stem cells (hMSCs) were evaluated to analyze the osteogenic capacity of the surface. The coating incorporated 10.5 µg rhBMP2 on average per disc and did not change the surface morphology. The release profile showed a delivery of 14.5% of the incorporated growth factor during the first 24 h with a decline towards the end of the observation period with a total release of 31.3%. Cross-linking reduced the release with an almost complete suppression at 100% cross-linking. Alkaline Phosphatase was significantly increased on day 1 and day 21, indicating that the growth factor bound in the coating remains active and available after 3 weeks. Proliferation of hMSCs was significantly enhanced by the non-cross-linked PEM coating. Nanocoating using collagen/heparin-based PEMs can incorporate clinically relevant amounts of rhBMP2 on titanium surfaces with a retarded release and a sustained enhancement of osteogenic activity without changing the surface morphology.